JAM
VRTX icon

Jupiter Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Jupiter Asset Management’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$290K Buy
+583
New +$258K ﹤0.01% 486
2026
Q1 		– Sell
-480
Closed -$218K – 572
2025
Q4 		$218K Sell
480
-65,139
-99% -$28.1M ﹤0.01% 395
2025
Q3 		$25.7M Buy
+65,619
New +$27.4M 0.22% 131
2025
Q1 		– Sell
-78,166
Closed -$31.5M – 508
2024
Q4 		$31.5M Sell
78,166
-81,761
-51% -$37.9M 0.31% 109
2024
Q3 		$74.4M Buy
159,927
+159,342
+27,238% +$76.5M 0.65% 33
2024
Q2 		$274K Sell
585
-90,194
-99% -$39.1M ﹤0.01% 373
2024
Q1 		$37.9M Sell
90,779
-72,637
-44% -$30.7M 0.36% 92
2023
Q4 		$66.5M Buy
163,416
+117,210
+254% +$43.3M 0.66% 34
2023
Q3 		$16.1M Buy
46,206
+366
+0.8% +$128K 0.18% 161
2023
Q2 		$16.1M Sell
45,840
-125,179
-73% -$42.2M 0.18% 161
2023
Q1 		$53.8M Buy
171,019
+40,504
+31% +$12.1M 0.74% 26
2022
Q4 		$37.7M Buy
130,515
+38,968
+43% +$11.9M 0.55% 48
2022
Q3 		$26.5M Sell
91,547
-33,485
-27% -$9.63M 0.41% 64
2022
Q2 		$35.2M Sell
125,032
-985
-0.8% -$264K 0.5% 55
2022
Q1 		$32.9M Buy
126,017
+123,034
+4,125% +$29.2M 0.39% 79
2021
Q4 		$664K Sell
2,983
-303,880
-99% -$59.1M 0.01% 448
2021
Q3 		$55.7M Buy
306,863
+260,450
+561% +$50.9M 0.63% 33
2021
Q2 		$9.36M Buy
+46,413
New +$9.71M 0.1% 213
2021
Q1 		– Sell
-53,800
Closed -$12.7M – 667
2020
Q4 		$12.7M Buy
53,800
+26,174
+95% +$6.01M 0.13% 194
2020
Q3 		$7.51M Buy
+27,626
New +$7.62M 0.08% 252

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Jupiter Asset Management's VRTX Position: Q2 2026 in Review

Jupiter Asset Management opened a new position in Vertex Pharmaceuticals (VRTX) in Q2 2026: 583 shares worth $290K. The stake represents ﹤0.01% of the portfolio and ranks #486 among its holdings. This is a return to the name: Jupiter Asset Management previously reported a position in VRTX as recently as Q4 2025.

Jupiter Asset Management first reported a position in VRTX in Q3 2020 and has held it in 20 quarters since. The position peaked at $74.4M in Q3 2024. 1,747 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Jupiter Asset Management held 583 shares of Vertex Pharmaceuticals worth $290K as of Q2 2026.
  • Vertex Pharmaceuticals was a new Jupiter Asset Management position in Q2 2026.
  • Vertex Pharmaceuticals made up ﹤0.01% of Jupiter Asset Management's portfolio in Q2 2026, its #486 holding.
  • Jupiter Asset Management first reported a position in Vertex Pharmaceuticals in Q3 2020 and has held it in 20 quarters since.
  • Jupiter Asset Management's Vertex Pharmaceuticals position peaked at $74.4M in Q3 2024.
  • 1,747 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Jupiter Asset Management's 13F filing for Q2 2026, filed 10 Aug 2026.